Healthtech Company Asensus Surgical Announces FDA Clearance

Aitechpark05 Mar, 2021Technology

Indications Expand to Include New Procedures in Large General Surgery Market Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: TRXC) , a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery?, today announced the Company has received an additional FDA clearance for the Senhance Surgical System which allows for indication expansion in general surgery in the United States.